Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRX | STVN | CRNX | ||
| Company | Amneal Pharmaceuticals Inc | Stevanato Group S.P.A. | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 13.47 | 15.41 | 40.00 | ||
| High | 13.92 | 15.65 | 41.33 | ||
| Low | 13.34 | 15.10 | 39.71 | ||
| Latest | 13.91 | 15.53 | 41.00 | ||
| Change | +0.82 | +0.50 | +1.98 | ||
| % Change | +6.26% | +3.33% | +5.07% | ||
| Volume | 1,854,500 | 311,700 | 1,102,000 | ||
| 20-Day Average Volume | 1,746,235 | 678,805 | 1,159,790 | ||
| Previous Close | 13.09 | 15.03 | 39.02 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.51 | 14.10 | 37.44 | ||
| 20-Day Raw Stochastic | 99.55% | 95.65% | 96.05% | ||
| 20-Day Relative Strength | 61.40 | 54.84 | 54.64 | ||
| Weighted Alpha | +82.82 | -34.61 | +9.03 | ||
| Today's Opinion | 64% Buy | 56% Sell | 24% Sell | ||
| Previous Opinion | 40% Buy | 64% Sell | 64% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.93% since 04/10/26 | +14.87% since 04/10/26 | +3.96% since 04/10/26 | ||
| Low | 12.30 on 04/13/26 | 13.52 on 04/13/26 | 38.25 on 04/13/26 | ||
| High | 13.92 on 04/17/26 | 15.65 on 04/17/26 | 41.33 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +11.91% since 03/17/26 | +0.84% since 03/17/26 | +8.21% since 03/17/26 | ||
| Low | 11.71 on 03/24/26 | 12.89 on 03/27/26 | 33.10 on 03/30/26 | ||
| High | 13.92 on 04/17/26 | 15.65 on 04/17/26 | 41.33 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +3.73% since 01/16/26 | -21.37% since 01/16/26 | -26.77% since 01/16/26 | ||
| Low | 11.71 on 03/24/26 | 12.89 on 03/27/26 | 33.10 on 03/30/26 | ||
| High | 15.42 on 02/17/26 | 19.94 on 01/22/26 | 56.99 on 01/21/26 | ||
| 6-Month | |||||
| %Chg | +40.22% since 10/17/25 | -36.46% since 10/17/25 | -1.37% since 10/17/25 | ||
| Low | 9.92 on 10/20/25 | 12.89 on 03/27/26 | 33.10 on 03/30/26 | ||
| High | 15.42 on 02/17/26 | 27.99 on 10/24/25 | 57.99 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,376,490 | 4,703,152 | 4,292,905 | ||
| Shares Outstanding, K | 314,629 | 302,843 | 104,705 | ||
| Annual Sales | 3,018,760,000 | 1,342,160,000 | 7,700,000 | ||
| Annual Net Income | 72,060,000 | 158,210,000 | -465,320,000 | ||
| Last Quarter Sales | 814,320,000 | 399,570,000 | 6,160,000 | ||
| Last Quarter Net Income | 35,080,000 | 54,410,000 | -122,820,000 | ||
| 60-Month Beta | 1.32 | 0.62 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 02/27/26 | 0.21 on 03/04/26 | -1.29 on 02/26/26 | ||
| Latest Earnings Date | 05/01/26 | 05/14/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.22 | 25.05 | 0.00 | ||